In this study, we also found that serum GDF15 levels were weakly associated with pulmonary function, moderately associated with clinical symptoms, and weakly associated with body composition in patients with COPD, and our results are consistent with previous reports (25, 45). Here, GDF15 is linked to chronic obstructive pulmonary disease.